Sheba Medical Center researchers ultimately found no difference in the rate of pregnancy between the vaccinated and unvaccinated test groups.
The immune response to COVID-19 helps protect against reinfection, but that protection is weaker against Omicron than it was against earlier variants of the coronavirus, according to new data.
A joint Russian-Italian study compared the blood serum of people who had received the different vaccines.
The CEOs of Pfizer and Moderna say they are preparing a booster targeting Omicron. Pfizer CEO Albert Bourla is still unsure if there is a need for the fourth booster.
The Jerusalem Post Health & Wellness Podcast with Maayan Hoffman and Rossella Tercatin
Molnupiravir received Emergency Use Authorization on Thursday evening in Israel. It is used to treat mild to moderate coronavirus in adults.
The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.
The US Centers for Disease Control and Prevention said that of the 43 cases attributed to the Omicron variant, 34 people had been fully vaccinated.
Among those who received a shot, a 90% reduction in COVID mortality was observed – 88% among men and 94% among women – compared to those who received only two doses.